Karl Goossens

Digital

At Veeva Commercial Summit this year, web editor Nicole Raleigh spoke with Karl Goossens, General Manager of OpenData Europe at Veeva Systems.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.